Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Brain Neoplasms 16Breast Neoplasms 12Glioblastoma 5Neoplasms 3Gliosarcoma 3Glioma 3Ependymoma 3Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 2 2Neoplasm Metastasis 2Lung Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms, Male 2Astrocytoma 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Recurrence 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neurilemmoma 1Medulloblastoma 1Glioma, Subependymal 1Familial ependymoma 1Esophageal Neoplasms 1Dysgerminoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Lapatinib 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Lapatinib × CNS × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡